Colrain Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
NC
Colrain Capital's TEVA Position: Q3 2017 in Review
Colrain Capital sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2017, closing a stake of 113,896 shares — an estimated $3.78M sold.
Colrain Capital first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $36.8M in Q4 2015. 538 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.
- Colrain Capital reported no remaining Teva Pharmaceutical Industries position as of Q3 2017 after selling out during the quarter.
- Colrain Capital sold 113,896 Teva Pharmaceutical Industries shares in Q3 2017, an estimated $3.78M.
- Colrain Capital first reported a position in Teva Pharmaceutical Industries in Q2 2013 and held it in 15 quarters.
- Colrain Capital's Teva Pharmaceutical Industries position peaked at $36.8M in Q4 2015.
- 538 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2017.
Based on Colrain Capital's 13F filing for Q3 2017, filed 2 Nov 2017.